<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The in vitro effect of increasing concentrations of <z:chebi fb="2" ids="26536">retinoic acid</z:chebi> on the growth of day 7 and day 14 CFU-GM and of pre-CFU-GM from patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> has been studied </plain></SENT>
<SENT sid="1" pm="."><plain>Unlike in <z:mpath ids='MPATH_458'>normal</z:mpath> cells, where <z:chebi fb="2" ids="26536">retinoic acid</z:chebi> enhances the in vitro growth of myeloid progenitors, there was an overall inhibition of bone marrow progenitors from patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> at concentrations of 10(-7) to 10(-6) M <z:chebi fb="2" ids="26536">retinoic acid</z:chebi>, with the exception of day 14 CFU-GM whose growth may be enhanced by 10(-7) M <z:chebi fb="2" ids="26536">retinoic acid</z:chebi> </plain></SENT>
</text></document>